Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.8591 | 36 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.78872 | 35 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.79217 | 35 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.7185 | 34 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.73819 | 35 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.83845 | 33 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.84415 | 35 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.76558 | 34 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.74483 | 34 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.7722 | 35 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.21854 | 51 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.69427 | 32 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.75076 | 33 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.77631 | 34 |